Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (31-40 of 442) with videos related to

Pageof 45
Sort By:
Cancer|February 23, 2018
T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT)Simona Sestili, Myriam Labopin, Annalisa Ruggeri, et al.
The Oncologist|December 7, 2014
Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationNoga Shem-Tov, Myriam Labopin, Leila Moukhtari, et al.
Leukemia|June 29, 2018
The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantationJoshua A Fein, Avichai Shimoni, Myriam Labopin, et al.
International Journal of Radiation Oncology, Biology, Physics|December 5, 2006
Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow TransplantationYazid Belkacémi, Myriam Labopin, Christophe Hennequin, et al.
Blood|March 16, 2006
Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disordersChristine Bellanné-Chantelot, Isabelle Chaumarel, Myriam Labopin, et al.
British Journal of Haematology|November 24, 2016
Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMTOlle Ringdén, Myriam Labopin, Christoph Schmid, et al.
Blood|May 19, 2010
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remissionNorbert-Claude Gorin, Myriam Labopin, Josy Reiffers, et al.
Haematologica|February 5, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow TransplantationMohamad Mohty, Myriam Labopin, Reza Tabrizzi, et al.
European Journal of Immunology|June 5, 2014
Tracking in vivo dynamics of NK cells transferred in patients undergoing stem cell transplantationMonica Killig, Birte Friedrichs, Johannes Meisig, et al.
The New England Journal of Medicine|November 27, 2004
Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemiaVanderson Rocha, Myriam Labopin, Guillermo Sanz, et al.
Pageof 45

Showing results (31-40 of 442) with videos related to

Sort By:
Pageof 45
Cancer|February 23, 2018
T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT)Simona Sestili, Myriam Labopin, Annalisa Ruggeri, et al.
The Oncologist|December 7, 2014
Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationNoga Shem-Tov, Myriam Labopin, Leila Moukhtari, et al.
Leukemia|June 29, 2018
The impact of individual comorbidities on non-relapse mortality following allogeneic hematopoietic stem cell transplantationJoshua A Fein, Avichai Shimoni, Myriam Labopin, et al.
International Journal of Radiation Oncology, Biology, Physics|December 5, 2006
Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow TransplantationYazid Belkacémi, Myriam Labopin, Christophe Hennequin, et al.
Blood|March 16, 2006
Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disordersChristine Bellanné-Chantelot, Isabelle Chaumarel, Myriam Labopin, et al.
British Journal of Haematology|November 24, 2016
Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMTOlle Ringdén, Myriam Labopin, Christoph Schmid, et al.
Blood|May 19, 2010
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remissionNorbert-Claude Gorin, Myriam Labopin, Josy Reiffers, et al.
Haematologica|February 5, 2008
Reduced intensity conditioning allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow TransplantationMohamad Mohty, Myriam Labopin, Reza Tabrizzi, et al.
European Journal of Immunology|June 5, 2014
Tracking in vivo dynamics of NK cells transferred in patients undergoing stem cell transplantationMonica Killig, Birte Friedrichs, Johannes Meisig, et al.
The New England Journal of Medicine|November 27, 2004
Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemiaVanderson Rocha, Myriam Labopin, Guillermo Sanz, et al.
Pageof 45